You may also like
Insight Into ECMO, Mortality and ARDS: A Nationwide Analysis of 45,647 ECMO Runs
ARDS is a severe disease with a high mortality rate despite ECLS therapy. Although endpoints and timing of the evaluations differed from those of the CESAR and EOLIA studies and the Extracorporeal Life Support Organization (ELSO) Registry, the reported mortality in these studies was lower than in the present analysis. Further prospective analyses are necessary to evaluate outcomes in ECMO therapy at the centre volume level.
1 min read
Outcomes of End-Organ Function and Survival with Veno-Arterial Extracorporeal Membrane Oxygenation.
Maintaining perfusion with VA-ECMO utilization on indicated patients demonstrated improvements in end-organ functions. Survival rates of VA-ECMO patients were also optimistic.
1 min read
Open Forum on Platelet Therapy & Clinical & Feasible Regenerative Medicine Treatment Options in the OR (EP Video)
The regenerative medicine market today includes first of all platelet-rich plasma (PRP) products, brought to market by a large variety of medical companies (52:34 minutes).
1 min read